SKI Market

A+| A| A-|

Indian Indices

Sensex

74,532.96 325.72
( 0.44%)

Global Indices

Nasdaq

46,043.89 -202.27
(-0.44%)

Dow Jones

6,628.50 -17.20
(-0.26%)

Hang Seng

53,297.18 -1,942.22
(-3.52%)

Nikkei 225

10,057.93 -247.36
(-2.40%)

Forex

USD-INR

92.72 0.33
(0.36%)

EUR-INR

106.76 0.38
(0.35%)

GBP-INR

123.58 0.43
(0.35%)

JPY-INR

0.58 0.00
(0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Zim Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

541400

INE518E01015

52.0221666

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ZIMLAB

44.95

363.16

EPS(TTM)

Face Value()

Div & Yield %

1.51

Back

maruti suzuki india ltd

Baid Finserv standalone net profit rises 132.14% in the September 2025 quarter

Nov 14,2025

Net profit of Baid Finserv rose 132.14% to Rs 4.55 crore in the quarter ended September 2025 as against Rs 1.96 crore during the previous quarter ended September 2024. Sales rose 21.51% to Rs 23.84 crore in the quarter ended September 2025 as against Rs 19.62 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	23.84	19.62	22
OPM %	59.27	53.52	-
PBDT	6.28	2.91	116
PBT	6.08	2.62	132
NP	4.55	1.96	132

74,532.96 325.72 ( 0.44%)

46,043.89 -202.27 (-0.44%)

6,628.50 -17.20 (-0.26%)

53,297.18 -1,942.22 (-3.52%)

10,057.93 -247.36 (-2.40%)

92.72 0.33 (0.36%)

106.76 0.38 (0.35%)

123.58 0.43 (0.35%)

0.58 0.00 (0.28%)